Executive summary
DossiMed operates at the intersection of three structural megatrends: the digitisation of health records in the Global South, the explosion of smartphone ownership in Africa and the Maghreb, and the monetisation of cross-border diaspora communities that carry documents between two healthcare systems simultaneously.
This report quantifies the opportunity across 16 countries — Tunisia, Morocco, Algeria, Senegal, Côte d'Ivoire, Nigeria, Ghana, Kenya, South Africa, France, Egypt, Cameroon, DRC, United Kingdom, Canada, and Australia — using January 2025 DataReportal figures, GSMA Mobile Economy Africa 2025 data, Statista Market Outlooks, RevenueCat's State of Subscription Apps 2025, and Spotify/Netflix PPP pricing grids as benchmarks.
Three headline findings: (1) The combined smartphone-using adult population in DossiMed's 16 markets is roughly 560–600 million people, sitting on top of a >$60B African + ~$10B French digital health market with mid-teens CAGRs through 2030. (2) PPP-tiered pricing at €2.99–€4.99/mo is well-validated for Tier 1–2 markets but must drop to ~€0.99/mo for Nigeria, Egypt, and DRC to drive conversion. (3) Realistic blended freemium-to-paid conversion is 2–4%, with blended ARPU on paying users of €2.50–€3.50/mo — yielding a Year-3 revenue corridor of €900K–€2.4M on 2–3.5M cumulative downloads.
1. Global mHealth market — TAM foundation
Published 2024 valuations of the global mHealth market diverge depending on scope. The table below presents the major sources with stated scope.
| Source | mHealth apps market (2024 baseline) | CAGR | Scope |
|---|---|---|---|
| Grand View Research | $37.5B → $86.4B by 2030 | 14.8% | Apps only |
| Fortune Business Insights | $36.7B → $88.7B by 2032 | 11.8% | Apps only |
| Precedence Research | $43.1B (2025) → $154.1B (2034) | 15.2% | Apps only |
| FactMR | $71.0B → $194.0B (2034) | 10.6% | Apps + wearables |
| ResearchAndMarkets | $134.3B → $639.6B (2030) | 29.7% | Broadest (incl. telehealth) |
Working consensus: apps-only mHealth market at ~$37–45B globally in 2024, growing at 14–15% CAGR through 2030. North America holds ~30–38% revenue share; Europe ~20–25%; Middle East & Africa together 4–7% but growing fastest (Africa digital-health revenue $5.58B in 2025 → $7.59B by 2029, Statista; Grand View projects 23.4% CAGR through 2030 for Africa).
Personal Health Record (PHR), Medication Management, and Disease Management apps are the primary sub-categories directly relevant to DossiMed.
TAM corridor for DossiMed's specific niche (consumer PHR + prescription/document management):
- 2025: ~$3.0–4.5B (8–10% of mHealth apps market)
- 2028: ~$5.5–8.0B at 14–17% CAGR
2. Country-by-country market data
DossiMed targets three distinct market clusters: the Maghreb (Francophone North Africa), sub-Saharan Africa (both Francophone and Anglophone), and Anglophone Western markets (UK, Canada, Australia) alongside France — where diaspora communities represent the highest-ARPU early-adopter cohort and the natural organic growth engine into home-country markets.
Maghreb
Tunisia (pop. 12.3M, 84.9% internet penetration, ~7–8M smartphone users): No national e-Rx or PHR — 70–85% of prescriptions remain paper. Digital health market ~$130–170M with ~7–8% CAGR. Diabetes 14%, hypertension 28–32%. WhatsApp penetration ~80–85%. DossiMed's French/Arabic bilingual core matches the linguistic split precisely.
Morocco (pop. 37.8M, ~92% internet, ~26–28M smartphone users): Digital health market $234.7M (2024) → $341.7M (2029) at 7.80% CAGR. Diabetes 12.4%, hypertension 32.4% — among the highest NCD burdens in the Maghreb. A "Shared Medical Record" agreement signed in 2024 remains non-operational. WhatsApp ~85%. Morocco is DossiMed's highest-priority Maghreb launch market.
Algeria (pop. 47.2M, 76.9% internet, ~27–30M smartphone users): Paper-dominant prescriptions (80–90%). Digital health ~$200–250M, CAGR 7–9%. FX restrictions limit Google Play billing — mobile-money fallback rails are critical for monetisation.
Francophone sub-Saharan Africa
Senegal (pop. 18.7M, 60.6% internet, ~7–8M smartphone users): Only 0.6 doctor visits per capita per year. Paper prescriptions 80–95%. WhatsApp ~88%. High mobile money penetration (Orange Money/Wave) — mobile-money billing is the default payment layer.
Côte d'Ivoire (pop. 32.3M, 39.6% internet, ~10–12M smartphone users): WhatsApp near-universal among connected users (94% Statcounter). Very high mobile money penetration (Orange/MTN/Wave). DH market ~$80–110M, CAGR 9–11%.
Cameroon (pop. 29.5M, 41.9% internet, ~10–11M smartphone users): Bilingual (FR/EN) — ideal structural fit for DossiMed. Paper prescriptions 90%+. Digital health ~$60–80M.
DRC (pop. 111M, 30.6% internet, ~12–18M smartphone users): Largest Francophone Africa population. Paper prescriptions 95%+. Very low purchasing power — pricing must anchor to $1.99/mo USD equivalent.
Anglophone sub-Saharan Africa
The four anglophone African markets below represent ~390 million people combined, with no credible patient-owned, AI-structured PHR serving them in English. Nigeria, Ghana, Kenya, and South Africa are DossiMed's anglophone Africa cornerstone — greenfield by design.
Nigeria (pop. 235M, 45.4% internet, ~80–100M smartphone users): Largest market by volume. Diabetes ~5–6%, hypertension ~25–35%. WhatsApp 95% penetration — highest in West Africa. Mobile money (OPay/PalmPay, 35M+ users). Africa digital health CAGR 23.4% (Grand View). Zero dominant patient-owned PHR exists.
Ghana (pop. 34.7M, 69.9% internet, ~14–16M smartphone users): WhatsApp 91.8%. Mobile money globally ranked #1 (MMRI score). Digital health ~$120–150M, CAGR 10–12%. No national PHR; mHealth scaling at community-health-worker level only.
Kenya (pop. ~57M, ~48% internet, ~25–30M smartphone users): M-Pesa universal — 82% adult mobile money penetration. WhatsApp 97% (highest in Africa). Digital health $284.7M projected by 2029. KenyaEMR is facility-side only — no patient-owned cross-provider PHR exists.
South Africa (pop. 64.4M, 78.9% internet, ~50M smartphone users): Highest iOS share in Africa (~15%). Hypertension 46% — highest on the continent. Pharma market ~$5–6B (22% of Africa's total). Subscription payments mature; Spotify $3.23/mo.
MENA
Egypt (pop. 117M, 81.9% internet, ~70–75M smartphone users): Diabetes 17–20% — very high. Vezeeta dominant for booking (60K doctors) but no structured PHR. FX devaluation 2023–24 makes USD-anchored pricing punitive; local PPP anchor is essential.
France + Anglophone Western markets
These markets deliver the highest ARPU per user and the most predictable subscription infrastructure. They are also the organic growth engine: diaspora users who adopt DossiMed pull in family members in home countries at near-zero CAC.
France (pop. 66.6M, ~93% internet, ~58–60M smartphone users): Mon Espace Santé has 24M activated profiles but no AI OCR of user-uploaded documents, no WhatsApp/voice escalation, no support for documents issued outside France. DH market ~$13.5B. ~6M Maghrebi-origin + 3–4M sub-Saharan-origin residents are DossiMed's primary diaspora wedge in Europe.
United Kingdom (pop. 67M, ~98% internet, ~63M smartphone users): ~2.5M MENA + African diaspora. NHS App covers NHS-registered patients only — the entire diaspora population receiving care outside the NHS is excluded. No Arabic, no AI OCR, no multilingual document structuring. High spend per user; £18B digital health market by 2025 at 15% CAGR.
Canada (pop. 41.5M, ~93% internet, ~33M smartphone users): ~1.5M Arab-Canadians + ~1.5M Black Canadians. Quebec is strongly francophone (Montreal CMA = 5.85% Arab population). Provincial EHRs exist but no national consumer PHR app. CA$36B+ pharma market. High ARPU potential, especially Francophone Quebec + MENA Ontario diaspora.
Australia (pop. 27.2M, ~96% internet, ~26M smartphone users): ~600–800K MENA + African diaspora (Lebanese, Egyptian, African-born). My Health Record exists nationally but has notoriously low engagement and no multilingual support. Highest ARPU per capita in the set; A$30B+ pharma market.
3. PPP-tiered pricing — benchmarked to Spotify and Netflix
DossiMed's stated €2.99–€4.99/mo band is consistent with mid-tier Africa + Maghreb benchmarks — but the market spans four distinct PPP zones.
| Zone | Countries | Spotify Premium | Netflix Basic | Recommended DossiMed | Annual equiv. |
|---|---|---|---|---|---|
| Tier 1 — High-income / Diaspora | France, UK, Canada, Australia | €11.99 | €10.99 | €4.99 / £4.49 / CA$5.99 / A$6.99 | ~€39.99/yr |
| Tier 2 — Maghreb + South Africa | Morocco, Tunisia, Algeria, South Africa | $3.23–$4.99 | $1.46–$3.48 | ~€3.40–€3.85 | ~€27–30/yr |
| Tier 3 — Anglophone West/East Africa | Nigeria, Kenya, Ghana | $0.56–$2.30 | Mobile $1–$2.30 | ~€0.95–€1.55 | ~€8–13/yr |
| Tier 4 — Francophone West/Central + Egypt | Senegal, CIV, Cameroon, DRC, Egypt | $1.04–$4.10 | $1.46–$4.10 | ~€0.95–€2.25 | ~€8–18/yr |
Critical operational note: Google Play Billing in Algeria, Nigeria, Egypt, and DRC is fragile due to FX controls. A mobile-money rails layer (Flutterwave + Paystack + Orange Money + M-Pesa) is not optional — it is the difference between 10–20% of theoretical conversion and actual monetisation in Tier 3/4 markets.
Key methodology notes:
- The €2.99–€4.99 band only fits Tier 1–2. Tier 3/4 requires a ~€0.99/mo floor for conversion to work.
- Annual plans at ~33% discount follow Spotify/Netflix patterns. Annual uptake assumption: 25% Year 1 → 45% Year 3.
- FX volatility (Naira, Egyptian Pound, Ghanaian Cedi, Algerian Dinar all devalued 30–60% in 2023–24) — set annual PPP-indexed price reviews, not fixed local-currency anchors.
4. Freemium conversion and retention benchmarks
All figures synthesised from RevenueCat State of Subscription Apps 2025, Business of Apps Health & Fitness benchmarks, ChartMogul, and Adapty.
| Metric | Benchmark | DossiMed assumption | Source |
|---|---|---|---|
| Freemium → paid (all categories, median) | 1.7% | — | RevenueCat 2025 |
| Health & Fitness freemium-only median | ~2.18% | — | RevenueCat 2025 |
| Health & Fitness hard-paywall average | ~12.11% | — | RevenueCat 2025 |
| DossiMed blended (freemium + 7-day trial) | — | 2.5% Y1 / 3.5% Y2 / 4.0% Y3 | Conservative consensus |
| D1 activation rate (health/fitness) | 26% | 35–45% (PHR has concrete utility) | Business of Apps |
| D30 retention (free tier) | 3% | 10–15% | Business of Apps; adjusted up |
| D90 retention (free) | ~5% | 6–9% | Inferred |
| Annual subscription retention (H&F) | 33% | 50–65% (paying users) | Business of Apps; adjusted |
| CPI — EMEA (paid acquisition) | $1.03 | $0.30–$1.20 (Africa) / $1.50–$3.00 (Diaspora) | BusinessOfApps / Mapendo 2024 |
| CAC (organic: ASO + WhatsApp + influencer) | — | $2–$8 | Inferred |
| CAC (paid) | — | $8–$25 (diaspora) / $8–$30 (Africa, conversion-diluted) | Inferred |
| Blended paid ARPU/month (PPP-weighted) | — | €2.50–€3.50 | Calculated from Tier 1–4 mix |
| Revenue per install (RPI) Day-60, health | $0.63 | — | RevenueCat 2025 |
| Organic k-factor (WhatsApp share + family) | — | 0.15 Y1 → 0.35 Y3 | Conservative; family-PHR has natural sharing |
Africa-specific adjustment: Actual African freemium-to-paid conversion is likely 30–50% below the global median due to payment friction, even at correct PPP pricing. DRC, Nigeria, Algeria, and Egypt are most affected. This is not a demand problem — it is a billing-rails problem, fully solvable with mobile money integration.
5. Three-year financial model anchors
All figures are base-case modeling anchors. Build sensitivity toggles (±50%) on conversion rate, blended ARPU, churn, and FX.
| Driver | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| TAM — smartphone-using adults 18–65 | 540M | 565M | 590M |
| SAM (smartphone + WhatsApp + paid-app-capable) | ~140M | ~155M | ~170M |
| Cumulative downloads | 250K–500K | 800K–1.5M | 2.0M–3.5M |
| MAU / total users ratio | 35–45% | 30–40% | 25–35% |
| Paying-user share (of cumulative) | 1.5–2.5% | 2.5–3.5% | 3.0–4.0% |
| Blended paid ARPU/month | €2.20 | €2.60 | €3.00 |
| Annual plan uptake (among paid) | 25% | 35% | 45% |
| Monthly churn (paid) | 8–10% | 6–8% | 5–7% |
| Gross margin on subscription | 70% | 75% | 78% |
| Server + AI extraction cost (per active user/mo) | €0.08 | €0.06 | €0.05 |
| Blended CPI (paid acquisition) | $1.30 | $1.10 | $0.95 |
| Blended CAC (per paying user) | $14–$22 | $11–$17 | $8–$13 |
| Marketing budget | €80–150K | €200–400K | €400–800K |
| Headcount (FTE) | 4–6 | 8–12 | 14–22 |
| Baseline revenue corridor | €40K–€120K | €250K–€700K | €900K–€2.4M |
SOM calculation methodology: Year-3 SOM = 0.5–1.5% of SAM (~140–170M). Comparable health-cohort apps reach 0.3–2% of SAM in comparable African markets within 36 months. The revenue corridor assumes 80% Africa + 20% diaspora download mix, with diaspora contributing ~40–50% of paid revenue despite being 20% of downloads.
6. The diaspora flywheel — high-ARPU bridgehead
The ~8–12 million combined Maghrebi + sub-Saharan adults in France, UK, Canada, and Australia represent a profitable bridgehead, not the long-term volume play. But they matter disproportionately in Year 1–2:
- ARPU is 1.5–2× home-country ARPU (Tier 1 pricing, stable FX, mature payment infrastructure)
- They are the natural first adopters — they already navigate two healthcare systems simultaneously
- Organic viral loop: a diaspora user sharing a family vault with a parent in Tunis or Lagos creates a cross-border download event at near-zero CAC
- Word-of-mouth within Maghrebi/West-African community networks is a high-leverage distribution channel that paid CPI cannot replicate
A Tunisian immigrant in Paris managing her own records (France), her elderly mother's prescriptions in Tunis (Maghreb), and her Nigerian-French husband's medication plan — then sharing the folder with both a French GP and a Tunisian cardiologist via the no-login link — is a use case structurally impossible to serve with any single existing competitor. It is DossiMed's most powerful word-of-mouth scenario and the core driver of the organic k-factor assumption in the financial model.
7. Sensitivity priorities
Build these as toggles in the financial model:
| Lever | Bear case | Base case | Bull case |
|---|---|---|---|
| Freemium → paid conversion | 1.5% | 2.5–4.0% | 6.0% |
| Blended ARPU (paying users) | €1.80/mo | €2.50–€3.50/mo | €4.50/mo |
| Monthly churn (paid) | 12% | 6–10% | 4% |
| Organic k-factor | 0.05 | 0.15–0.35 | 0.60 |
| Google Play billing failure rate (NG/EG/DZ/DRC) | 60% | 35% | 10% (with MoMo rails) |
| Year-3 revenue | ~€350K | €900K–€2.4M | ~€4.5M |
Conclusion
The structural opening DossiMed addresses is real, large, and underserved. Across 16 markets, the combination of paper-dominant prescriptions (70–95%), fragmented or absent national PHRs, a trilingual gap (FR/AR/EN) unaddressed by any single competitor, and rapidly growing smartphone + mobile-money infrastructure creates conditions for a freemium PHR to achieve significant scale.
Key financial model anchors
- TAM: ~$3.0–4.5B consumer PHR/document management niche within ~$37–45B global mHealth apps market (2025), growing at 14–17% CAGR
- SAM: ~140–170M smartphone + WhatsApp + paid-app-capable adults across 16 markets (2025–2027)
- SOM Year 3: 0.5–1.5% of SAM = 700K–2.5M users; 3–4% paid conversion = 21K–100K paying users
- Blended ARPU: €2.50–€3.50/mo on paying users (PPP-weighted); €30–€42/yr
- Year-3 revenue corridor: €900K–€2.4M (base case); bear €350K; bull ~€4.5M
- Critical unlock: Mobile-money payment rails in Tier 3/4 markets — without them, the financial model is structurally capped at ~30–40% of its potential
Methodology: All figures cross-checked against DataReportal Digital 2025 country reports, GSMA Mobile Economy Africa 2025, GSMA Mobile Economy MENA 2025, Statista Market Outlooks (Digital Health, Pharmaceuticals, Smartphones 2024–25), Grand View Research, MarketDataForecast, RevenueCat State of Subscription Apps 2025, Business of Apps Health & Fitness Benchmarks 2026, WHO 2024 Health Statistics, and Ministère de la Santé France (Mon Espace Santé). Where sources conflict, ranges are presented and the most-reputable primary source is preferred.